Background/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by the accumulation of triglycerides within hepatocytes. which can progress to more severe conditions. such as metabolic dysfunction-associated steatohepatitis (MASH). which may include progressive fibrosis. https://www.spidertattooz.com/